RADIOTHERAPY BRIDGING IN LARGE B‐CELL LYMPHOMA PATIENTS RECEIVING CD19 CAR‐T – THE UK EXPERIENCE.

Authors :: Kuhnl, A.
Roddie, C.
Kirkwood, A.
Chaganti, S.
Norman, J.
Lugthart, S.
Osborne, W.
Gibb, A.
Arias, C. Gonzalez
Latif, A.
Uttenthal, B.
Seymour, F.
Jones, C.
Springell, D.
Brady, J.
Illidge, T.
Stevens, A.
Alexander, E.
Hawley, L.
O'Rourke, N.
Source :: Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p217-218, 2p
Publication Year :: 2023
Abstract: High-precision, individualised RT protocols allowed successful tumour de-bulking with limited toxicity, providing the basis to develop specific RT bridging protocols in lymphoma. RADIOTHERAPY BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CD19 CAR-T - THE UK EXPERIENCE B Background: b Radiotherapy (RT) has potential synergistic effects with CAR T but is not widely used as bridging therapy for lymphoma patients due to logistical challenges, uncertainty about patient selection and lack of standardised protocols. [Extracted from the article]

Full Text Access

Tools